Abstract
The discovery of inositol monophosphatase (IMPase) activity inhibition by lithium (Li) ions led to Berridge’s inositol depletion hypothesis, and brain inositol levels have been studied in relation to psychiatric disorders. We have previously reported low myo-inositol levels in the frontal cortex of bipolar and schizophrenic patients and low IMPase activity in lymphocyte-derived cell lines from this group of patients. In the present study, myo- and scyllo-inositol levels and IMPase activity were measured in the Stanley Brain Consortium postmortem brain specimens from bipolar patients and normal controls. No differences were found between the diagnostic groups in any parameter in any brain area studied. There was a positive correlation between myo- and scyllo-inositol in frontal and occipital cortex. We could not replicate our previous report of low myo-inositol levels in the frontal cortex of bipolar patients. In subjects treated with neuroleptic drugs, there was no correlation between myo-inositol levels and estimated chlorpromazine equivalents administered peri mortem.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
